Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2163
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1629
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
25
Water Analysis
13
Arecoline hydrobromide
(11161105 | 300-08-3)
CAS: | 300-08-3 |
---|---|
Formule moléculaire: | C8H13NO2 · HBr |
Masse moléculaire: | 236.11 |
Disponibilité: | En stock |
---|---|
Téléchargements: | | |
11161105-25g | 25g | £120.90 | |
Commande en vrac |
11161105-25g | 25g | €169.30 | |
Commande en vrac |
11161105-25g | 25g | $181.40 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 11161105 | ||||
Product Name | Arecoline hydrobromide | ||||
Categories | Antibiotics Bioactive Small Molecules Biochemicals Research Organics & Inorganics | ||||
CAS | 300-08-3 | ||||
Molecular Formula | C8H13NO2 · HBr | ||||
Molecular Weight | 236.11 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 29397990 |
Spécifications du produit
Melting Point | 171 - 173 Deg C | ||||
Heavy metals | <10ppm | ||||
Identification | GC-MS | ||||
Loss on Drying | <0.5% | ||||
Solution | Clear and Transparent | ||||
Appearance | White crystalline powder | ||||
Assay (dry basis) | 98 - 100% |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|